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ATL is a highly aggressive T-cell neoplasm caused by
HTLV-1. We have recently demonstrated that EZH2, a
catalytic enzyme of histone H3K27 methylation, is over-
expressed in ATL cells, which contributes to persistent
NF-B activation by repressing a tumor-suppressive
miRNA, miR-31. This suggests that epigenetic abnormal-
ities are closely associated with the molecular hallmarks
of leukemic cells. However, the mechanisms by which
epigenetic disruption is caused and sustained in HTLV-1
infected cells remain to be clarified. In the present study,
we first found that Tax directly interacts with EZH2 in
HTLV-1 infected cells. Given that epigenetic state is
directly affected by cell lineage-dependent transcription
factors and genetic background, we assessed the func-
tional interconnection between HTLV-1 Tax and the his-
tone methyltransferases in an appropriate model. Using a
lentivirus vector, we introduced tax gene into peripheral
blood mononuclear cells (PBMCs) and CD4+ T-cells
from healthy donors and established Tax-transduced
T-cells. In this model, we observed overexpression of
EZH2, aberrant accumulation of H3K27 trimethylation,
and epigenetic silencing of p21cip1/waf1, all of which have
been observed in primary ATL cells. In addition, EZH2
inhibition reduced the viability of Tax-transduced
T-cells. Our results strongly suggest that Tax epigeneti-
cally affects gene expression through its interaction with
EZH2, and that Tax-dependent epigenetic abnormalities
may be involved in determining the molecular character-
istics of HTLV-1-infected cells as well as ATL cells. Since
epigenetic marks are potentially reversible, development
of genuine epigenetic-targeted drugs will hold great pro-
mise in treatment of HTLV-1-related diseases.
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